Probing the role of microenvironment for microencapsulated Sacchromyces cerevisiae under osmotic stress

Journal of Biotechnology

Volumn 128, Issue 1, 2007, Pages 150-161

  Sun, Zhi Jie ^a,b   Lv, Guo Jun ^a,b   Li, Shuang Yue ^a,b   Xie, Yu Bing ^a   Yu, Wei Ting ^a   Wang, W ^a   Ma, Xiao Jun ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Alginate; Microcapsule; Microenvironment; Osmotic stress; Viability; Yeast

Indexed keywords

CELLS; ENCAPSULATION; GLYCEROL; OSMOSIS; YEAST;

ALGINATE; MICROCAPSULE; MICROENVIRONMENT; OSMOTIC STRESS;

BIOTECHNOLOGY;

ALGINATE CHITOSAN ALGINATE; ALGINIC ACID; CALCIUM ALGINATE; CHITOSAN; GLYCEROL; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TREHALOSE;

ARTICLE; CELL PROTECTION; CHEMICAL STRESS; GENETIC ENGINEERING; HUMAN; HUMAN CELL; MICROENCAPSULATION; MICROENVIRONMENT; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SOLID CORE MICROCAPSULE; TECHNOLOGY;

ALGINATES; DRUG COMPOUNDING; GLUCURONIC ACID; HEXURONIC ACIDS; MATERIALS TESTING; MICROBIAL VIABILITY; OSMOLAR CONCENTRATION; SACCHAROMYCES CEREVISIAE; SALINE SOLUTION, HYPERTONIC;

SACCHAROMYCES CEREVISIAE;

EID: 33845633921     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.09.001     Document Type: Article

References (46)

1. Albertyn J., Hohmann S., Thevelein J.M., and Prior B.A. GPD1, which encodes glycerol-3-phosphate dehydrogenase, is essential for growth under osmotic stress in Saccharomyces cerevisiae, and its expression is regulated by the high-osmolarity glycerol response pathway. Mol. Cell. Biol. 14 (1994) 4135-4144
2. Angelova M.B., Pashova S.B., and Slokoska L.S. Comparison of antioxidant enzyme biosynthesis by free and immobilized Aspergillus niger cells. Enzyme Microb. Technol. 26 (2000) 544-549
3. Attfield P.V. Stress tolerance: the key to effective strains of industrial baker's yeast. Nat. Biotechnol. 15 (1997) 1351-1357
4. Beauchamp C., and Fridovich I. Superoxide dismutase: improved assays and an applicable to polyacrylamide gels. Anal. Biochem. 44 (1971) 276-287
5. Beninati C., Oggioni M.R., Boccanera M., Spinosa M.R., Maggi T., Conti S., Magliani W., De' Bernardis F., Teti G., Cassone A., Pozzi G., and Polonelli L. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 18 (2000) 1060-1064
6. Bisping B., Baumann U., and Rehm H.J. Production of glycerol by immobilized Pichiafarinose. Appl. Microbiol. Biotechnol. 32 (1990) 380-386
7. Brewster J.L., De Valoir T., Dwyer N.D., Winter E., and Gustin M.C. An osmosensing signal transduction pathway in yeast. Science 259 (1993) 1760-1763
8. Byrd W., De Lorimier A., Zheng Z.R., and Cassels F.J. Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens. Adv. Drug Deliv. Rev. 57 (2005) 1362-1380
9. Chang H.N., Seong G.H., Yoo I.K., Park J.K., and Seo J.H. Microencapsulation of recombinant Saccharomyces cerevisiae cells with invertase activity in liquid-core alginate capsules. Biotechnol. Bioeng. 51 (1996) 157-162
10. Chang T.M. Therapeutic applications of polymeric artificial cells. Nat. Rev. Drug Discov. 4 (2005) 221-235
11. Chang T.M., and Prakash S. Artificial cells for bioencapsulation of cells and genetically engineered E. coli for cell therapy, gene therapy, and removal of urea and ammonia. Meth. Mol. Biol. 63 (1997) 343-358
12. Chow J.N., Liu Z.C., Prakash S., and Chang T.M.S. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif. Cells Blood Subst. Biotechnol. 31 (2003) 425-435
13. Coquet L., Junter G.A., and Jouenne T. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. J. Antimicrob. Chemother. 42 (1998) 755-760
14. Groot M., Schuurs T.A., and van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121 (2004) 141-150
15. Desimone M.F., Degrossi J., Aquino M.D., and Diaz L.E. Sol-gel immobilization of Saccharomyces cerevisiae enhances viability in organic media. Biotechnol. Lett. 25 (2003) 671-674
16. Dror Y., Cohen O., and Freeman A. Stabilization effect on immobilized yeast: effect of gel composition on tolerance to water miscible solvent. Enzyme Microb. Technol. 10 (1988) 273-279
17. Duff R.G. Microencapsulation technology: a novel method for monoclonal antibody production. Trends Biotechnol. 3 (1985) 167-170
18. Fan J., Whiteway M., and Shen S.H. Disruption of a gene encoding glycerol-3-phosphatase from Candida albicans impairs intracellular glycerol accumulation-mediated salt-tolerance. FEMS Microbiol. Lett. 245 (2005) 107-116
19. Gerlinde K. Influence of stress on adherent cells. Adv. Biochem. Eng./Biotechnol. 67 (2000) 124-137
20. Hansen L.T., Allan-Wojtas D.M., Jin Y.C., and Paulson A.T. Survival of Ca-alginate microencapsulated Bifidobacterium spp in milk and simulated gastrointestinal conditions. Food Microbiol. 10 (2002) 35-45
21. Hari P.R., Chandy T., and Sharma C.P. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 13 (1996) 319-329
22. Herbert D., Phipps P.J., and Strange R.E. Chemical analysis of microbial cells. Meth. Microbiol. 5B (1971) 210-344
23. Hilge-Rotmann B., and Rehm H.J. Comparison of fermentation properties and specific enzyme activities of free and calcium-alginate-entrapped Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 33 (1990) 54-58
24. Hohmann S. Osmotic stress signaling and osmoadaptation in yeasts. Microbiol. Mol. Biol. Rev. 66 (2002) 300-372
25. Hounsa C.G., Brandt E.V., Thevelein J., Hohmann S., and Prior B.A. Role of trehalose in survival of Saccharomyces cerevisiae under osmotic stress. Microbiology 144 (1998) 671-680
26. Joki T., Machluf M., Atala A., Zhu J., Seyfried N.T., Dunn I.F., Abe T., Carroll R.S., and Black P.M. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19 (2001) 35-39
27. Kruger C., Hu Y., Pan Q., Marcotte H., Hultberg A., Delwar D., van Dalen P.J., Pouwels P.H., Leer R.J., Kelly C.G., van Dollenweerd C., Ma J.K., and Hammarstrom L. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol. 20 (2002) 702-706
28. Lutolf M.P., and Hubbell J.A. Synethentic biomaterial for morphogenesis in tissue engineering. Nat. Biotechnol. 23 (2005) 47-55
29. Mager W.H., de Boer A.H., Siderius M.H., and Voss H.P. Cellular responses to oxidative and osmotic stress. Cell Stress Chaperones 5 (2000) 73-75
30. Mandal S., Puniya A.K., and Singh K. Effect of alginate concentrations on survival of microencapsulated Lactobacillus casei NCDC-298. Inter. Dairy J. 16 (2006) 1190-1195
31. Norton S., Watson K., and D'Amore T. Ethanol tolerance of immobilized brewers' yeast cells. Appl. Microbiol. Biotechnol. 43 (1995) 18-24
32. Ouyang W., Chen H., Jones M.L., Metz T., Haque T., Martoni C., and Prakash S. Artificial cell microcapsule for oral delivery of live bacterial cells for therapy: design, preparation, and in-vitro characterization. J. Pharm. Sci. 7 (2004) 315-324
33. Orive G., Hernández R.M., Gascón A.R., Igartua M., and Pedraz J.L. Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 18 (2003) 23-30
34. O'Loughlin J.A., Bruder J.M., and Lysaght M.J. Oral administration of biochemicallly active microcapsules to treat uremia: new insights into an old approach. J. Biomat. Sci. (Polymer Edition) 15 (2004) 1447-1461
35. Park J.K., Cheong K.S., and Chang H.N. The effect of oxygen transfer on the activity of encapsulated whole cell β-galactosidase. Bioprocess Eng. 17 (1997) 197-202
36. Polk A., Amsdent B., Yao De K., Peng T., and Goosen M.F.A. Controlling released of albumin from alginate-chitosan microcapsules. J. Pharm. Sci. 83 (1994) 178-185
37. Prakash S., and Bhathena J. Live bacterial cells as orally delivered therapeutics. Expert Opin. Biol. Ther. 5 (2005) 1281-1301
38. Prakash S., and Chang T.M. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2 (1996) 883-887
39. Prakash S., and Chang T.M. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells. Int. J. Artif. Organs 23 (2000) 429-435
40. Qi W.T., Yu W.T., Xie Y.B., and Ma X.J. Optimization of saccharomyces cerevisiae culture in alginate-chitosan-alginate microcapsules. Biochem. Eng. J. 25 (2005) 151-157
41. Read T.A., Sorensen D.R., Mahesparan R., Enger P.O., Timpl R., Olsen B.R., Hjelstuen M.H., Haraldseth O., and Bjerkvig R. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19 (2001) 29-34
42. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., and Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000) 1352-1355
43. Steidler L., Neirynck S., Huyghebaert N., Snoeck V., Vermeire A., Goddeeris B., Cox E., Remon J.P., and Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21 (2003) 785-789
44. Shen H.Y., Moonjai N., Verstrepen K.J., and Delvaux F.R. Impact of attachment immobilization on yeast physiology and fermentation performance. J. Am. Soc. Brew Chem. 61 (2003) 79-87
45. Wang W., Liu X.D., Xie Y.B., Zhang H.A., Yu W.T., Xiong Y., Xie W.Y., and Ma X.J. Microencapsulation using natural polysaccharides for drug delivery and cell implantation. J. Mater. Chem. 16 (2006) 3252-3267
46. Zhang X.L., Wang W., Yu W.T., Xie Y.B., Zhang X.H., Zhang Y., and Ma X.J. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol. Prog. 21 (2005) 1289-1296